Daniel Tsung-Ning Huang

Daniel Tsung-Ning Huang

Auto-generated profile, based on publicly available information

Daniel Tsung-Ning Huang

Department of Pediatrics, MacKay Children's Hospital, No. 92, Sec. 2, Zhongshan N. Rd., Taipei City 10449, Taiwan; Department of Medicine, MacKay Medical College, No.46, Sec. 3, Zhongzheng Rd., Sanzhi Dist., New Taipei City 252005, Taiwan

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2009 in Journal of the Formosan Medical Association
Verified
Journal Article
Closed access
LCLuan-Yin Chang
Luan-Yin Chang
SSShin-Ru Shih
Shin-Ru Shih
PSPei-Lan Shao
Pei-Lan Shao
DHDaniel Tsung-Ning Huang
Daniel Tsung-Ning Huang
LHLi-Min Huang
Li-Min Huang

1 July 2006 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
DHDaniel Tsung-Ning Huang
Daniel Tsung-Ning Huang
HCHsin Chi
Hsin Chi
HLHung-Chang Lee
Hung-Chang Lee
NCNan-Chang Chiu
Nan-Chang Chiu
FHFu-Yuan Huang
Fu-Yuan Huang
Among the most severe complications of invasive pneumococcal infection are hemolytic uremic syndrome (P-HUS) and hemolytic anemia (P-HA), which occur when the Thomsen-Freidenreich antigen (TA) is exposed on erythrocytes, platelets and glomeruli. To determine the positive predictive value, sensitivity, and specificity of early TA activation testing for P-HUS or P-HA and to compare the microbiologic features of pneumococcus isolates associated or not associated with TA activation. The case records for 36 patients with invasive pneumococcal infection who had been tested for TA activation were retrospectively reviewed. Clinical and laboratory data were compared between patients with and without TA activation. Positive TA activation was 86% sensitive and 57% specific for P-HUS or P-HA. The positive predictive value was 76%. There were no between-group differences in antibiotic susceptibility of the pneumococcal isolates. Pneumococcal serotype 14 was the most frequent (5/10 isolates tested) serotype causing P-HUS. Of the 36 patients, 13 required packed red blood cell transfusion, 3 died, and 2 required extracorporeal membrane oxygenation. No patient had long-term renal sequelae. TA activation is a reasonable predictor of P-HUS or P-HA and could be useful if tested soon after invasive pneumococcal disease is first diagnosed.

1 June 2011 in Journal of Microbiology, Immunology and Infection
Verified
Journal Article
Closed access
CSChi-Chun Sung
Chi-Chun Sung
HCHsin Chi
Hsin Chi
NCNan-Chang Chiu
Nan-Chang Chiu
DHDaniel Tsung-Ning Huang
Daniel Tsung-Ning Huang
LWLi-Chuan Weng
Li-Chuan Weng
FHFu-Yuan Huang
Fu-Yuan Huang

1 October 2016 in Journal of Microbiology, Immunology and Infection
Verified
Journal Article
Open access
YLYen-I Lee
Yen-I Lee
CPChun-Chih Peng
Chun-Chih Peng
NCNan-Chang Chiu
Nan-Chang Chiu
DHDaniel Tsung-Ning Huang
Daniel Tsung-Ning Huang
FHFu-Yuan Huang
Fu-Yuan Huang
HCHsin Chi
Hsin Chi
Respiratory syncytial virus (RSV) infection is an important cause of viral respiratory tract infection in children. This retrospective study describes the clinical characteristics of severe RSV infection and determines the risk factors for death. Patients were identified through a review of all patients discharged with a diagnosis of RSV lower respiratory tract infection and admitted to hospital in the pediatric intensive care unit (PICU) of a tertiary medical center between July 1, 2001 and June 30, 2010. The medical and demographic variables were recorded and analyzed. The 186 RSV-positive patients admitted to the PICU had a median age of 5.3 months (interquartile range 2.3-12.4 months) and included 129 boys and 57 girls. Among them, 134 had at least one underlying disease: prematurity in 92, neurological disease in 57, bronchopulmonary dysplasia in 40, congenital heart disease in 26, hematological malignancies in 11, and Down's syndrome in nine patients. The 10 patients who died from RSV-related causes had a median age of 20.8 months (interquartile range 6.6-89.2 months) and all had a comorbidity. In multivariate analysis, the risk factors for death in severe RSV infection were Down's syndrome (odds ratio 7.20, 95% confidence interval 1.13-45.76; p = 0.036) and nosocomial RSV infection (odds ratio 4.46, 95% confidence interval 1.09-18.27; p = 0.038). Down's syndrome and nosocomial RSV infection are significantly associated with death in severe RSV infections. Clinicians should be alert to these conditions.

1 August 2015 in Vaccine
Verified
Journal Article
Closed access
WLWen-Li Lin
Wen-Li Lin
NCNan-Chang Chiu
Nan-Chang Chiu
PLPin-Hui Lee
Pin-Hui Lee
AHAngela Song-En Huang
Angela Song-En Huang
FHFu-Yuan Huang
Fu-Yuan Huang
PCPei-Chun Chan
Pei-Chun Chan

1 August 2017 in Journal of Microbiology, Immunology and Infection
Verified
Journal Article
Open access
JCJia Lu Cheng
Jia Lu Cheng
CPChun-Chih Peng
Chun-Chih Peng
NCNan-Chang Chiu
Nan-Chang Chiu
LWLi-Chuan Weng
Li-Chuan Weng
YCYu-Ying Chiu
Yu-Ying Chiu
HCHsin Chi
Hsin Chi
Respiratory infections caused by human adenoviruses (HAdV) are worldwide, and have significantly increased recently in Taiwan. This study aimed to clarify the molecular epidemiology and risk factors of HAdV severe infections and pneumonia among Taiwanese children. Patients with HAdV infections and hospitalized in a medical center between 2009 and 2013 were divided into severe or nonsevere HAdV infections based on whether or not they received intensive care. HAdV pneumonia was identified for comparison. The HAdV genotype was determined by sequencing the partial hexon and fiber genes. The nucleotide sequences were compared by phylogenetic analysis. The 176 patients (97 boys, 79 girls) had a median age of 3.7 years. The HAdV infections circulated year-round. HAdV B3 (54.5%) was the most common genotype, followed by HAdV C2 (21%), HAdV E4 (8%), and HAdV B7 (6.8%). Thirty-two patients needed intensive care. In multivariate analysis, the risk factors for severe HAdV infections were underlying neurologic diseases [odds ratio (OR): 164.9; p < 0.001], prematurity (OR: 10.9; p = 0.042), and HAdV B7 (OR: 39.5; p = 0.011). Twenty-nine patients had HAdV pneumonia. Patients with underlying neurologic diseases (OR 76.8; p < 0.001), airway anomaly (OR 15.1; p = 0.033), chronic lung diseases (OR 12.5; p = 0.047), weight < 3rd percentile (OR 5.5; p = 0.027), and HAdV B7 (OR 4.2; p = 0.002) had higher incidences of pneumonia. Four with underlying neurologic diseases died of acute respiratory distress syndrome. HAdV infections circulate all year-round. HAdV B7 is strongly related to severe infections and pneumonia. Underlying neurologic diseases and prematurity are risk factors for severe HAdV infections.